StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.77+0.03 (+1.09%)

Close on Nov 16, 2026Market cap $23.10MP/E –Yield –

Evaxion A/S operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -122.7%, against -440.6% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-122.7%+317.9
FY2024Dec 31, 2024-440.6%+29966.3
FY2023Dec 31, 2023-30406.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2025Jun 30, 2025-11729.7%–
Q2 FY2024Jun 30, 2024-2974.7%–

More Evaxion A/S figures

See a number that looks wrong?